Latest Strategic Partnership News

European Lithium Limited reported strong Q2 2025 progress with significant share sales in Critical Metals Corp raising over A$12.8 million, alongside promising exploration and development updates across Greenland, Austria, Ireland, and Australia.

Environmental Clean Technologies Limited has secured crucial regulatory approvals for its Bacchus Marsh fertiliser facility and completed a $275K capital raise, while deferring field trials to better align with cropping cycles. The company is also undergoing significant restructuring to improve capital efficiency and focus on strategic growth.

Cambium Bio has raised A$2.12 million through a fully subscribed placement led by Taiwanese institutional investor Da Jyun Capital, supporting the initiation of pivotal Phase 3 trials for its lead ophthalmology candidate.

Diatreme Resources has achieved a significant milestone with its Northern Silica Project awarded Major Project Status and a 278% upgrade in its Si2 Deposit resource, positioning the company for long-term growth in the critical minerals sector.

Magnis Energy Technologies progresses detailed engineering on its Nachu Graphite Project and moves to fast track US anode material production, while navigating ASX suspension and IM3NY bankruptcy fallout.

Codeifai Limited has raised $2.35 million through a share placement to fund key acquisitions and expand its footprint in quantum computing and AI. The move signals a strategic push towards U.S. market engagement and commercialisation of cutting-edge technology.

Uscom Limited reported a significant revenue decline in Q4 2025 amid global market instability but is focusing on cost management and strategic partnerships to position for recovery.

ReNerve Limited reported a robust 53% increase in annual revenue, driven by strategic partnerships and new regulatory approvals that broaden its global footprint in nerve repair.

Vital Metals Limited has released a comprehensive Scoping Study for its Tardiff Rare Earths deposit in Canada, revealing strong economic potential with an 11-year mine life and significant neodymium-praseodymium resources.

Syntara Limited reports encouraging Phase 2 data for its lead drug amsulostat in myelofibrosis, secures FDA Fast Track status, and expands clinical programs into myelodysplastic syndrome and keloid scars.

Magnetite Mines has increased its Razorback iron ore resource estimate and extended key partnership negotiations, advancing its flagship project’s development. The company also reported promising metallurgical testwork and drew down funding to support ongoing feasibility studies.

TMK Energy has commenced drilling its seventh pilot well at the Gurvantes XXXV Coal Seam Gas Project, reporting positive reservoir pressure tests and advancing partnerships to fast-track development.